ALLEN JOHN LOVEY,ERIC BRIAN SJOGREN,HONGJU LI,JAVIER DE VICENTE FIDALGO,JOHANNES CORNELIUS HERMANN,MICHAEL SOTH,REMY LEMOINE
申请号：
BR112012005382
公开号：
BR112012005382A2
申请日:
2010.09.07
申请国别(地区):
BR
年份:
2016
代理人:
摘要：
The present invention relates to the use of novel compounds of Formula I, wherein the variables m, n, p, q, Q, r, R, R', X, X', Y, Z1, Z2, and Z3 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.
